Was Jim Cramer Right About These 23 Stocks?
During the latest episode of Mad Money, Jim Cramer advised his viewers to closely monitor the upcoming Federal Reserve meeting and the earnings reports from companies.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ion Asset Management Stephen Levey And Jonathan Half | 36,650,000 | $807,766,000 | 47.02% | |
| 2. | Rubric Capital Management David Rosen | 17,000,000 | $374,680,000 | +7% | 4.8% |
| 3. | Point State Capital Zach Schreiber | 13,526,475 | $298,123,509 | +39% | 5.43% |
| 4. | Slate Path Capital David Greenspan | 8,491,033 | $187,142,367 | -38% | 3.38% |
| 5. | Glenview Capital Larry Robbins | 8,456,324 | $186,377,381 | 4.71% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | Director | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | Director | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | Officer | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | Director | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | Director | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.90 | 48,385 | 48,384 | 2025-03-05 | Filing | ||
| $15.91 | 22,576 | 96,769 | 2025-03-05 | Filing | ||
| $15.91 | 2,147 | 58,384 | 2025-03-05 | Filing | ||
| $15.73 | 4,034 | 60,531 | 2025-03-04 | Filing | ||
| $15.91 | 1,677 | 11,914 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 81,983,231 | $1,806,910,406 | 0.1% | |
| 2. | 50,583,826 | $1,114,867,517 | 0.02% | |
| 3. | 28,381,242 | $625,522,574 | 3.92% | |
| 4. | 27,192,388 | $599,320,232 | 16.07% | |
| 5. | 21,212,542 | $467,524,857 | 6.37% |
News See All
10 Best Weight Loss Drug Stocks to Buy According to Analysts
Most people have tried to include fitness and weight loss into their everyday routines.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
Top 12 Stocks to Buy According to Bourgeon Capital
Bourgeon Capital Management LLC is an investment advisory firm headquartered in Darien, Connecticut.
Is Teva Pharmaceutical (TEVA) Trading at a Discount?
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A copy of the letter can be downloaded here.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2024 Earnings Call Transcript January 29, 2025Teva Pharmaceutical Industries Limited beats earnings expectations.
12 Best Middle East and Africa Stocks To Buy Right Now
Global financial giants are increasingly turning their attention to the Middle East and are establishing operations in cities such as Dubai, Abu Dhabi, and Riyadh.
10 Firms Kick Off 2025 Trading in The Red
Share prices of Aurora Innovation dropped for a fourth consecutive day on Thursday as investors continued to sell off positions over concerns that the US electric vehicle (EV) industry is now being dominated...
10 Biggest Gainers of Last Week
Investors gobbled up shares of predominantly technology companies last week, following announcements of multi-billion dollars of investments, quantum technology backing, and new contracts, among others...
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.